- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Wockhardt Ltd (WCKH)Wockhardt Ltd stock price live, this page displays NS WCKH stock exchange data. View the WCKH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Wockhardt Ltd real time stock price chart below.
What Is the Wockhardt Ltd Stock Price Today?
The Wockhardt Ltd stock price today is 1,404.25.
What Is the Stock Symbol for Wockhardt Ltd?
The stock symbol for Wockhardt Ltd is "WCKH."
What Stock Exchange Does Wockhardt Ltd Trade On?
Wockhardt Ltd is listed and trades on the NSE stock exchange.
Is Wockhardt Ltd a Good Stock to Buy?
Determining whether Wockhardt Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WCKH quote. (ISIN: INE049B01025)
What Is the Wockhardt Ltd Stock Price Today?
The Wockhardt Ltd stock price today is 1,404.25.
What Is the Stock Symbol for Wockhardt Ltd?
The stock symbol for Wockhardt Ltd is "WCKH."
What Stock Exchange Does Wockhardt Ltd Trade On?
Wockhardt Ltd is listed and trades on the NSE stock exchange.
Is Wockhardt Ltd a Good Stock to Buy?
Determining whether Wockhardt Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the WCKH quote. (ISIN: INE049B01025)
1,404.25
+48.20(+3.55%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,345.00
1,418.00
52 wk Range
326.35
1,418.00
WCKH Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Trading near 52-week High
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,345.001,418.00
52 wk Range
326.351,418.00
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockWCKH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Wockhardt Company Profile
Wockhardt Limited, a pharmaceutical and biotech company, manufactures and trades pharmaceuticals, medicinal, botanical, and chemical products in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. The company develops qualified infectious diseases products comprising WCK5222, which is in phase 3 clinical trial for the treatment of sepsis and hospital/ventilator associated pneumonia; WCK 4282, which is in phase 3 clinical trial for ESBL infections; WCK 6777, which is phase 1 to treat gram negative infections; and WCK 4873, which is phase 3 clinical trial for community-acquired bacterial pneumonia. It also offers rapid and long-acting insulin analogues, concentrated insulins, GLP1 analogues, haemopoietins, biobetters and novel products, and delivery devices. In addition, the company develops and commercializes Biovac-B, a hepatitis B vaccine; WEPOX, a recombinant human erythropoietin; WOSULIN, a recombinant human insulin; and GLARITUS, a recombinant insulin glargine. Further, it provides contract manufacturing services; offers and active pharmaceutical ingredients. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Compare WCKH to Peers and Sector
Metrics to compare | WCKH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipWCKHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −79.2x | 33.0x | −0.7x | |
PEG Ratio | −1.76 | 1.12 | 0.00 | |
Price/Book | 6.7x | 5.9x | 2.6x | |
Price / LTM Sales | 7.7x | 5.1x | 3.2x | |
Upside (Analyst Target) | - | 9.5% | 40.8% | |
Fair Value Upside | Unlock | −12.7% | 5.7% | Unlock |
FAQ
What Is the Wockhardt (WCKH) Stock Price Today?
The Wockhardt stock price today is 1,404.25.
What Stock Exchange Does Wockhardt Trade On?
Wockhardt is listed and trades on the NSE stock exchange.
What Is the Stock Symbol for Wockhardt?
The stock symbol for Wockhardt is "WCKH."
What Is the Wockhardt Market Cap?
As of today, Wockhardt market cap is 228.15B.
What is Wockhardt Earnings Per Share?
The Wockhardt EPS is -19.64.
What Is the Next Wockhardt Earnings Date?
Wockhardt will release its next earnings report on 02 Feb 2025.
From a Technical Analysis Perspective, Is WCKH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.